| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Arterial Disease | 19 | 2025 | 291 | 6.270 |
Why?
|
| Ischemia | 21 | 2025 | 362 | 5.520 |
Why?
|
| Endovascular Procedures | 16 | 2024 | 737 | 2.710 |
Why?
|
| Vascular Surgical Procedures | 12 | 2022 | 577 | 2.530 |
Why?
|
| Lower Extremity | 9 | 2025 | 187 | 2.420 |
Why?
|
| Limb Salvage | 18 | 2025 | 133 | 2.310 |
Why?
|
| Vascular System Injuries | 4 | 2021 | 54 | 1.850 |
Why?
|
| Blood Vessel Prosthesis Implantation | 11 | 2022 | 804 | 1.840 |
Why?
|
| Stents | 11 | 2020 | 888 | 1.510 |
Why?
|
| Risk Factors | 35 | 2025 | 10282 | 1.300 |
Why?
|
| Intestinal Fistula | 3 | 2020 | 28 | 1.300 |
Why?
|
| Vascular Fistula | 3 | 2020 | 31 | 1.280 |
Why?
|
| Wound Healing | 9 | 2025 | 460 | 1.200 |
Why?
|
| Aortic Diseases | 4 | 2019 | 199 | 1.190 |
Why?
|
| Risk Assessment | 17 | 2025 | 3455 | 1.170 |
Why?
|
| Carotid Stenosis | 3 | 2019 | 143 | 1.130 |
Why?
|
| Cardiovascular Agents | 2 | 2022 | 90 | 1.110 |
Why?
|
| Prosthesis-Related Infections | 4 | 2022 | 179 | 1.110 |
Why?
|
| Time Factors | 25 | 2025 | 6327 | 1.040 |
Why?
|
| Diabetic Foot | 6 | 2025 | 163 | 1.030 |
Why?
|
| Arteries | 2 | 2017 | 224 | 1.000 |
Why?
|
| Treatment Outcome | 34 | 2025 | 12382 | 0.940 |
Why?
|
| Aged | 38 | 2025 | 19859 | 0.880 |
Why?
|
| Subclavian Artery | 2 | 2016 | 73 | 0.850 |
Why?
|
| Sex Distribution | 2 | 2021 | 306 | 0.840 |
Why?
|
| Chronic Disease | 9 | 2025 | 1195 | 0.840 |
Why?
|
| Cardiovascular System | 1 | 2024 | 106 | 0.840 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2017 | 731 | 0.830 |
Why?
|
| Retrospective Studies | 32 | 2025 | 16312 | 0.810 |
Why?
|
| Aortic Aneurysm, Abdominal | 3 | 2019 | 449 | 0.750 |
Why?
|
| Drug-Eluting Stents | 1 | 2022 | 64 | 0.730 |
Why?
|
| Patient Selection | 5 | 2021 | 699 | 0.720 |
Why?
|
| Iatrogenic Disease | 1 | 2021 | 133 | 0.710 |
Why?
|
| Middle Aged | 33 | 2025 | 26922 | 0.700 |
Why?
|
| Chi-Square Distribution | 9 | 2017 | 590 | 0.670 |
Why?
|
| Male | 44 | 2025 | 61439 | 0.670 |
Why?
|
| Humans | 66 | 2025 | 125037 | 0.660 |
Why?
|
| Angioplasty, Balloon | 4 | 2016 | 172 | 0.660 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 183 | 0.660 |
Why?
|
| Vascular Diseases | 1 | 2021 | 168 | 0.650 |
Why?
|
| Aorta, Abdominal | 3 | 2019 | 126 | 0.630 |
Why?
|
| Aorta, Thoracic | 3 | 2018 | 531 | 0.620 |
Why?
|
| Postoperative Complications | 5 | 2024 | 3069 | 0.610 |
Why?
|
| Endarterectomy, Carotid | 1 | 2019 | 100 | 0.590 |
Why?
|
| Renal Dialysis | 1 | 2024 | 854 | 0.570 |
Why?
|
| Female | 42 | 2025 | 66721 | 0.570 |
Why?
|
| Forecasting | 1 | 2019 | 352 | 0.560 |
Why?
|
| Registries | 4 | 2020 | 1431 | 0.560 |
Why?
|
| Aorta | 3 | 2021 | 545 | 0.550 |
Why?
|
| Kidney Failure, Chronic | 1 | 2024 | 880 | 0.540 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1096 | 0.540 |
Why?
|
| Kaplan-Meier Estimate | 9 | 2024 | 1053 | 0.530 |
Why?
|
| Depression | 1 | 2025 | 1236 | 0.520 |
Why?
|
| Femoral Vein | 2 | 2017 | 51 | 0.510 |
Why?
|
| Surgical Flaps | 1 | 2018 | 203 | 0.510 |
Why?
|
| Axillary Artery | 1 | 2016 | 28 | 0.500 |
Why?
|
| Cause of Death | 1 | 2018 | 475 | 0.500 |
Why?
|
| Diabetes Complications | 1 | 2017 | 202 | 0.490 |
Why?
|
| Health Status Disparities | 2 | 2024 | 228 | 0.490 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2022 | 546 | 0.480 |
Why?
|
| Aneurysm, Infected | 2 | 2012 | 25 | 0.470 |
Why?
|
| Aneurysm, False | 2 | 2012 | 103 | 0.420 |
Why?
|
| Prevalence | 3 | 2025 | 2452 | 0.420 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 337 | 0.410 |
Why?
|
| United States | 13 | 2024 | 10909 | 0.400 |
Why?
|
| Cardiovascular Infections | 1 | 2012 | 7 | 0.390 |
Why?
|
| Vascular Patency | 4 | 2020 | 214 | 0.390 |
Why?
|
| Thrombophlebitis | 1 | 2012 | 22 | 0.390 |
Why?
|
| Popliteal Vein | 1 | 2011 | 10 | 0.380 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 1957 | 0.380 |
Why?
|
| Diabetes Mellitus | 2 | 2017 | 873 | 0.380 |
Why?
|
| Venous Thrombosis | 3 | 2023 | 183 | 0.370 |
Why?
|
| Incidence | 5 | 2025 | 3137 | 0.330 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2010 | 93 | 0.330 |
Why?
|
| Machine Learning | 2 | 2023 | 251 | 0.330 |
Why?
|
| Proportional Hazards Models | 5 | 2024 | 1356 | 0.330 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 1039 | 0.320 |
Why?
|
| Quality of Life | 3 | 2024 | 1939 | 0.320 |
Why?
|
| Atherosclerosis | 2 | 2016 | 920 | 0.320 |
Why?
|
| Exercise Therapy | 2 | 2023 | 153 | 0.320 |
Why?
|
| Thrombectomy | 3 | 2024 | 107 | 0.310 |
Why?
|
| Critical Illness | 5 | 2019 | 601 | 0.310 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 2906 | 0.310 |
Why?
|
| Sex Factors | 3 | 2024 | 1287 | 0.310 |
Why?
|
| Texas | 7 | 2016 | 3586 | 0.300 |
Why?
|
| Cross Infection | 1 | 2011 | 325 | 0.300 |
Why?
|
| Stroke | 3 | 2016 | 986 | 0.300 |
Why?
|
| Survival Rate | 5 | 2020 | 2057 | 0.290 |
Why?
|
| Hospital Mortality | 4 | 2019 | 1025 | 0.280 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 1437 | 0.280 |
Why?
|
| Acute Disease | 4 | 2024 | 1110 | 0.270 |
Why?
|
| Reoperation | 4 | 2022 | 833 | 0.270 |
Why?
|
| Aged, 80 and over | 12 | 2024 | 6597 | 0.260 |
Why?
|
| Logistic Models | 6 | 2017 | 1809 | 0.260 |
Why?
|
| Vascular Grafting | 2 | 2018 | 47 | 0.260 |
Why?
|
| Comorbidity | 3 | 2017 | 1532 | 0.250 |
Why?
|
| Device Removal | 2 | 2021 | 221 | 0.250 |
Why?
|
| Leg | 1 | 2006 | 158 | 0.240 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2025 | 50 | 0.230 |
Why?
|
| Embolism | 1 | 2024 | 48 | 0.220 |
Why?
|
| Odds Ratio | 4 | 2017 | 1256 | 0.220 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 290 | 0.220 |
Why?
|
| Myofibrils | 1 | 2023 | 28 | 0.220 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 3424 | 0.220 |
Why?
|
| Intermittent Claudication | 1 | 2023 | 58 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2024 | 208 | 0.210 |
Why?
|
| Early Ambulation | 1 | 2022 | 8 | 0.210 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2023 | 133 | 0.200 |
Why?
|
| Predictive Value of Tests | 3 | 2025 | 2168 | 0.200 |
Why?
|
| Angioplasty | 2 | 2014 | 89 | 0.200 |
Why?
|
| Thrombosis | 2 | 2024 | 525 | 0.190 |
Why?
|
| Leg Ulcer | 1 | 2021 | 11 | 0.190 |
Why?
|
| Disease-Free Survival | 2 | 2014 | 899 | 0.190 |
Why?
|
| Prognosis | 2 | 2023 | 4630 | 0.190 |
Why?
|
| Renal Artery Obstruction | 2 | 2012 | 40 | 0.190 |
Why?
|
| Patient Advocacy | 1 | 2021 | 62 | 0.180 |
Why?
|
| Paclitaxel | 1 | 2022 | 130 | 0.180 |
Why?
|
| Recurrence | 2 | 2016 | 1420 | 0.170 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 172 | 0.170 |
Why?
|
| Retreatment | 2 | 2019 | 89 | 0.170 |
Why?
|
| History, 21st Century | 1 | 2021 | 266 | 0.170 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 5169 | 0.170 |
Why?
|
| Coinfection | 1 | 2022 | 171 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 241 | 0.170 |
Why?
|
| Frail Elderly | 1 | 2020 | 96 | 0.160 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 222 | 0.160 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 174 | 0.160 |
Why?
|
| Iliac Artery | 1 | 2019 | 92 | 0.160 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 124 | 0.160 |
Why?
|
| Wearable Electronic Devices | 1 | 2020 | 105 | 0.160 |
Why?
|
| Pain | 1 | 2022 | 450 | 0.150 |
Why?
|
| Disease Progression | 1 | 2025 | 2061 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 433 | 0.150 |
Why?
|
| Frailty | 1 | 2020 | 106 | 0.150 |
Why?
|
| Myocytes, Cardiac | 1 | 2023 | 625 | 0.150 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 377 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2022 | 4812 | 0.150 |
Why?
|
| Wound Infection | 1 | 2018 | 53 | 0.150 |
Why?
|
| Patient Participation | 1 | 2020 | 220 | 0.140 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 221 | 0.140 |
Why?
|
| Thoracic Injuries | 1 | 2018 | 90 | 0.140 |
Why?
|
| Surgical Mesh | 1 | 2018 | 61 | 0.140 |
Why?
|
| Length of Stay | 2 | 2020 | 1307 | 0.140 |
Why?
|
| Ankle Joint | 1 | 2017 | 35 | 0.140 |
Why?
|
| Adult | 11 | 2021 | 29625 | 0.140 |
Why?
|
| Wounds, Penetrating | 1 | 2018 | 141 | 0.140 |
Why?
|
| Vena Cava, Inferior | 1 | 2018 | 103 | 0.140 |
Why?
|
| Abdominal Injuries | 1 | 2018 | 112 | 0.140 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 642 | 0.140 |
Why?
|
| Laparotomy | 1 | 2018 | 135 | 0.140 |
Why?
|
| Glasgow Coma Scale | 1 | 2017 | 206 | 0.140 |
Why?
|
| Injury Severity Score | 1 | 2017 | 227 | 0.130 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2016 | 52 | 0.130 |
Why?
|
| Video Games | 1 | 2017 | 92 | 0.130 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 214 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 851 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 265 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 199 | 0.120 |
Why?
|
| Caregivers | 1 | 2020 | 575 | 0.120 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 3728 | 0.120 |
Why?
|
| Embolization, Therapeutic | 1 | 2017 | 219 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 664 | 0.120 |
Why?
|
| Kidney | 2 | 2012 | 1366 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 81 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2018 | 1504 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 42 | 0.110 |
Why?
|
| Life Style | 1 | 2016 | 415 | 0.110 |
Why?
|
| Metatarsal Bones | 2 | 2024 | 8 | 0.110 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 120 | 0.110 |
Why?
|
| Radiology, Interventional | 1 | 2013 | 28 | 0.100 |
Why?
|
| Triplets | 1 | 2013 | 11 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 444 | 0.100 |
Why?
|
| Radiation Dosage | 1 | 2013 | 135 | 0.100 |
Why?
|
| Radiography, Interventional | 1 | 2013 | 87 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2017 | 1179 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2016 | 1133 | 0.100 |
Why?
|
| Aneurysm | 1 | 2013 | 90 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 140 | 0.100 |
Why?
|
| Hypertension, Renovascular | 1 | 2011 | 29 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2014 | 618 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2013 | 198 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 148 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2013 | 120 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 946 | 0.090 |
Why?
|
| Health Care Costs | 1 | 2014 | 371 | 0.090 |
Why?
|
| Databases as Topic | 1 | 2011 | 72 | 0.090 |
Why?
|
| Blood Pressure | 3 | 2011 | 1369 | 0.090 |
Why?
|
| Smoking | 1 | 2016 | 1049 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2013 | 2100 | 0.090 |
Why?
|
| Age Factors | 1 | 2017 | 2817 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1239 | 0.090 |
Why?
|
| Georgia | 1 | 2010 | 30 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2013 | 378 | 0.090 |
Why?
|
| Endoleak | 1 | 2010 | 45 | 0.090 |
Why?
|
| Leukocytosis | 1 | 2010 | 46 | 0.090 |
Why?
|
| Ulcer | 1 | 2010 | 48 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2014 | 542 | 0.080 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 254 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 723 | 0.080 |
Why?
|
| Iliac Vein | 1 | 2010 | 34 | 0.080 |
Why?
|
| Leukocyte Count | 1 | 2010 | 250 | 0.080 |
Why?
|
| Bicycling | 1 | 2010 | 35 | 0.080 |
Why?
|
| Elective Surgical Procedures | 1 | 2010 | 160 | 0.080 |
Why?
|
| Hematoma | 1 | 2010 | 93 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 171 | 0.080 |
Why?
|
| Aortic Rupture | 1 | 2010 | 121 | 0.080 |
Why?
|
| Infant | 4 | 2018 | 12462 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2024 | 6153 | 0.080 |
Why?
|
| Anesthesia | 1 | 2011 | 207 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 238 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2018 | 13984 | 0.080 |
Why?
|
| Graft Survival | 1 | 2010 | 535 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2011 | 445 | 0.070 |
Why?
|
| Hypertension | 3 | 2011 | 1329 | 0.070 |
Why?
|
| Adolescent | 5 | 2018 | 19330 | 0.070 |
Why?
|
| Child | 5 | 2023 | 24356 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1267 | 0.070 |
Why?
|
| BRCA1 Protein | 1 | 2006 | 68 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2022 | 270 | 0.060 |
Why?
|
| Femoral Artery | 1 | 2006 | 194 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2009 | 479 | 0.060 |
Why?
|
| Fasciotomy | 1 | 2024 | 27 | 0.060 |
Why?
|
| Checkpoint Kinase 2 | 3 | 2009 | 36 | 0.060 |
Why?
|
| Young Adult | 5 | 2018 | 9045 | 0.050 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 405 | 0.050 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2023 | 31 | 0.050 |
Why?
|
| Diffusion | 1 | 2023 | 57 | 0.050 |
Why?
|
| Europe | 1 | 2024 | 354 | 0.050 |
Why?
|
| Renal Veins | 1 | 2023 | 36 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2009 | 1501 | 0.050 |
Why?
|
| Suction | 1 | 2023 | 54 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 282 | 0.050 |
Why?
|
| DNA Repair | 1 | 2006 | 585 | 0.050 |
Why?
|
| Water | 1 | 2023 | 186 | 0.050 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2010 | 663 | 0.050 |
Why?
|
| Rivaroxaban | 1 | 2022 | 55 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2025 | 260 | 0.050 |
Why?
|
| Clinical Competence | 3 | 2014 | 1002 | 0.050 |
Why?
|
| Aspirin | 1 | 2022 | 222 | 0.050 |
Why?
|
| Organ Size | 2 | 2012 | 436 | 0.040 |
Why?
|
| Benchmarking | 1 | 2021 | 137 | 0.040 |
Why?
|
| Professional-Patient Relations | 1 | 2020 | 84 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 1112 | 0.040 |
Why?
|
| Creatinine | 2 | 2012 | 390 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 1270 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 469 | 0.040 |
Why?
|
| Health Services Research | 1 | 2020 | 186 | 0.040 |
Why?
|
| DNA Damage | 2 | 2014 | 513 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 2 | 2012 | 504 | 0.040 |
Why?
|
| Mitochondria | 1 | 2023 | 682 | 0.040 |
Why?
|
| Biofeedback, Psychology | 1 | 2017 | 33 | 0.040 |
Why?
|
| Range of Motion, Articular | 1 | 2017 | 74 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2021 | 696 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 133 | 0.030 |
Why?
|
| Electromyography | 1 | 2017 | 165 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2020 | 539 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 209 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 443 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 264 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 244 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 475 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 195 | 0.030 |
Why?
|
| Communication | 1 | 2020 | 518 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2017 | 455 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2013 | 3156 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 762 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2018 | 385 | 0.030 |
Why?
|
| Thymocytes | 1 | 2014 | 8 | 0.030 |
Why?
|
| Carbazoles | 1 | 2014 | 33 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 118 | 0.030 |
Why?
|
| Acetylation | 1 | 2014 | 163 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1105 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 3345 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1397 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2013 | 91 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2013 | 69 | 0.030 |
Why?
|
| Saphenous Vein | 1 | 2013 | 60 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 17621 | 0.030 |
Why?
|
| Biomarkers | 2 | 2012 | 3081 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 736 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 357 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 2013 | 142 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2014 | 680 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2011 | 58 | 0.020 |
Why?
|
| Emergencies | 1 | 2011 | 170 | 0.020 |
Why?
|
| Renal Replacement Therapy | 1 | 2012 | 142 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2009 | 2633 | 0.020 |
Why?
|
| Workload | 1 | 2011 | 145 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1757 | 0.020 |
Why?
|
| Phlebography | 1 | 2010 | 50 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 1604 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2010 | 242 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 414 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 400 | 0.020 |
Why?
|
| Animals | 2 | 2023 | 34206 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2010 | 205 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2010 | 215 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 754 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 4403 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2006 | 303 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4259 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 1303 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 1632 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 3102 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3892 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3570 | 0.010 |
Why?
|
| Heart Failure | 1 | 2011 | 2297 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 2512 | 0.010 |
Why?
|